Spyre Therapeutics Inc

Research Spyre Therapeutics Inc (SYRE) on Bullrun: market cap USD 7.83B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerSYRE
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 7.83B
• Financial periodFY2025
• Net income-USD 155.20M

Valuation Snapshot

latest market cap is USD 7.83B.

About Spyre Therapeutics Inc

Spyre Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing therapeutics for patients living with inflammatory bowel disease (IBD) and rheumatic diseases. The company develops SPY001, a humanized monoclonal immunoglobulin G1 antibody that is in phase-2 clinical stage designed to bind selectively to the a4ß7 integrin being developed for the treatment of IBD (ulcerative colitis and Crohn's disease);

Frequently asked questions

What is Spyre Therapeutics Inc's market cap?

Spyre Therapeutics Inc's market capitalization is USD 7.83B.

What does Spyre Therapeutics Inc do?

Spyre Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing therapeutics for patients living with inflammatory bowel disease (IBD) and rheumatic diseases.